BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 11694407)

  • 1. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
    Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J
    Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene.
    Santamaría A; Mateo J; Oliver A; Menéndez B; Souto JC; Borrell M; Soria JM; Tirado I; Fontcuberta J
    Haematologica; 2001 Sep; 86(9):965-71. PubMed ID: 11532625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thrombotic risk in family members of unselected individuals with factor V Leiden.
    Lensen RP; Bertina RM; de Ronde H; Vandenbroucke JP; Rosendaal FR
    Thromb Haemost; 2000 Jun; 83(6):817-21. PubMed ID: 10896231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of venous thromboembolism in families with inherited thrombophilia.
    Simioni P; Sanson BJ; Prandoni P; Tormene D; Friederich PW; Girolami B; Gavasso S; Huisman MV; Büller HR; Wouter ten Cate J; Girolami A; Prins MH
    Thromb Haemost; 1999 Feb; 81(2):198-202. PubMed ID: 10063991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombophilia testing in patients with venous thrombosis.
    Caprini JA; Goldshteyn S; Glase CJ; Hathaway K
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):550-5. PubMed ID: 16055356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband.
    Rossi E; Ciminello A; Za T; Betti S; Leone G; De Stefano V
    Thromb Haemost; 2011 Oct; 106(4):646-54. PubMed ID: 21833444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of factor V Leiden and prothrombin G20210A gene mutation.
    Irdem A; Devecioglu C; Batun S; Soker M; Sucakli IA
    Saudi Med J; 2005 Apr; 26(4):580-3. PubMed ID: 15900364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal loss in women with hereditary thrombophilic defects and concomitance of other thrombophilic defects: a retrospective family study.
    Korteweg FJ; Folkeringa N; Brouwer JL; Erwich JJ; Holm JP; van der Meer J; Veeger NJ
    BJOG; 2012 Mar; 119(4):422-30. PubMed ID: 22324918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
    van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
    Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prothrombin 20210A allele influences clinical manifestations of hemophilia A in patients with intron 22 inversion and without inhibitors.
    Tizzano EF; Soria JM; Coll I; Guzmán B; Cornet M; Altisent C; Martorell M; Domenech M; del Río E; Fontcuberta J; Baiget M
    Haematologica; 2002 Mar; 87(3):279-85. PubMed ID: 11869940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis.
    Gurgey A; Haznedaroglu IC; Egesel T; Buyukasik Y; Ozcebe OI; Sayinalp N; Dundar SV; Bayraktar Y
    Am J Hematol; 2001 Jun; 67(2):107-11. PubMed ID: 11343382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia.
    Rossi E; Za T; Ciminello A; Leone G; De Stefano V
    Thromb Haemost; 2008 Jun; 99(6):1030-4. PubMed ID: 18521504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism.
    Bonduel M; Hepner M; Sciuccati G; Pieroni G; Feliú-Torres A; Mardaraz C; Frontroth JP
    Thromb Haemost; 2002 Jun; 87(6):972-7. PubMed ID: 12083504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency.
    Yap S; O'Donnell KA; O'Neill C; Mayne PD; Thornton P; Naughten E
    Thromb Haemost; 1999 Apr; 81(4):502-5. PubMed ID: 10235428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
    Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A
    Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism.
    Okumus G; Kiyan E; Arseven O; Tabak L; Diz-Kucukkaya R; Unlucerci Y; Abaci N; Unaltuna NE; Issever H
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):168-73. PubMed ID: 17895505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.